Jianmin Pharmaceutical Group Co (SHSE:600976) Debt-to-Equity : 0.06 (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Jianmin Pharmaceutical Group Co Debt-to-Equity?

Jianmin Pharmaceutical Group Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥109 Mil. Jianmin Pharmaceutical Group Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥45 Mil. Jianmin Pharmaceutical Group Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥2,545 Mil. Jianmin Pharmaceutical Group Co's debt to equity for the quarter that ended in Mar. 2025 was 0.06.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Jianmin Pharmaceutical Group Co's Debt-to-Equity or its related term are showing as below:

SHSE:600976' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.03 Max: 0.08
Current: 0.06

During the past 13 years, the highest Debt-to-Equity Ratio of Jianmin Pharmaceutical Group Co was 0.08. The lowest was 0.01. And the median was 0.03.

SHSE:600976's Debt-to-Equity is ranked better than
78.12% of 818 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs SHSE:600976: 0.06

Jianmin Pharmaceutical Group Co Debt-to-Equity Historical Data

The historical data trend for Jianmin Pharmaceutical Group Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jianmin Pharmaceutical Group Co Debt-to-Equity Chart

Jianmin Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

0.02

0.05

0.03

0.05

0.07

Jianmin Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Debt-to-Equity	Get a 7-Day Free Trial															0.05	0.06	0.08	0.07	0.06

Competitive Comparison of Jianmin Pharmaceutical Group Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Jianmin Pharmaceutical Group Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jianmin Pharmaceutical Group Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jianmin Pharmaceutical Group Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Jianmin Pharmaceutical Group Co's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Jianmin Pharmaceutical Group Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Jianmin Pharmaceutical Group Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(147.282	+	28.43)	/	2435.306
	=	0.07

Jianmin Pharmaceutical Group Co's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(108.559	+	45.005)	/	2545.483
	=	0.06

Jianmin Pharmaceutical Group Co (SHSE:600976) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Jianmin Pharmaceutical Group Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Jianmin Pharmaceutical Group Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Jianmin Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052

Website

http://www.whjm.com

Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.

Executives

Du Ming De	Director
He Qin	Director
Gao Kai	senior management
Wang Jun	senior management
Huang Zhi Jun	senior management
Pei Xue Jun	senior management
Bu Zhong Jiang	Director
Cheng Chao Yang	senior management
Xu Sheng	senior management
Hu Zhen Bo	senior management
Liu Qin Qiang	Director
Xiong Fu Liang	senior management
Liu Peng	senior management

Jianmin Pharmaceutical Group Co Headlines

No Headlines